martes, 21 de abril de 2026
Yahoo Finance

Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential

R
Redacción
Redacción · ayer
Lectura 2 min

Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential · DevFinanciero